⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6161007 | 0.64 | HSP90AA1 (0.40) | — | |
| SCHEMBL5330779 | 0.64 | — | — | |
| SCHEMBL16616831 | 0.64 | — | — | |
| SCHEMBL4807047 | 0.64 | — | — | |
| SCHEMBL4618582 | 0.64 | — | — | |
| SCHEMBL2040096 | 0.61 | — | — | |
| SCHEMBL6705296 | 0.59 | — | — | |
| SCHEMBL5094514 | 0.58 | — | — | |
| SCHEMBL5263372 | 0.57 | — | — | |
| SCHEMBL2040937 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370079-A2 | HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT | Novartis AG (CH) | 2011-10-05 | — | — | EP | disclosed |
| US-7871982-B2 | Lincomycin derivatives and antimicrobial agents comprising the same as active ingredient | MEIJI SEIKA KAISHA, LTD. (JP) | 2011-01-18 | — | — | US | disclosed |
| WO-2010060940-A2 | HSP90 INHIBITORS FOR THERAPEUTIC TREATMENT | NOVARTIS AG (CH) | 2010-06-03 | — | — | WO | disclosed |
| US-20090156512-A1 | potent activity against resistant pneumococci | MEIJI SEIKA KAISHA, LTD. (JP) | 2009-06-18 | — | — | US | disclosed |
| EP-1362047-A2 | INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS | Ortho-McNeil Pharmaceutical, Inc. (US) | 2003-11-19 | — | — | EP | disclosed |
| WO-2002046183-A2 | INDAZOLYL-SUBSTITUTED PYRROLINE COMPOUNDS AS KINASE INHIBITORS | ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) | 2002-06-13 | — | — | WO | disclosed |